Symbol="GOVXW"
AssetType="Common Stock"
Name="GeoVax Labs Inc"
Description="GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using a platform of modified vaccinia ankara virus-like particle vaccines in the United States and internationally. The company is headquartered in Smyrna, Georgia."
CIK="832489"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="1900 LAKE PARK DRIVE, SUITE 380, SMYRNA, GE"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="None"
EBITDA="-2048834"
PERatio="None"
PEGRatio="None"
BookValue="None"
DividendPerShare="None"
DividendYield="0"
EPS="None"
RevenuePerShareTTM="7.5"
ProfitMargin="-1.175"
OperatingMarginTTM="-1.172"
ReturnOnAssetsTTM="-1.98"
ReturnOnEquityTTM="0"
RevenueTTM="1758300"
GrossProfitTTM="0"
DilutedEPSTTM="0"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.099"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-"
Beta="1.629"
num_52WeekHigh="1.43"
num_52WeekLow="0.08"
num_50DayMovingAverage="0"
num_200DayMovingAverage="0"
SharesOutstanding="0"
DividendDate="None"
ExDividendDate="None"
symbol="GOVXW"
open="0.21"
high="0.21"
low="0.21"
price="0.21"
volume="235.00"
latest_trading_day="2023-07-21"
previous_close="0.21"
change="0.00"
change_percent="0.0000%"
aroon_positive_momentum_days="70"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="70"
Volume_recent_avg="2126"
Change_recent_avg="0.01"
Delta_recent_avg="0.02"
Variance_recent_avg="0.01"
Change_ratio_recent_avg="0.41"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="70"
Aroon_momentum_negative="30"
image_negative_thumbnail_id_1="1156"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="568"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0031.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="998"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0160.jpeg"
image_professor_thumbnail_id_1="1204"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0038.jpeg"
image_professor_thumbnail_id_2="1181"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0015.jpeg"
